Stock A225220 GENOLUTION INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Genolution Inc.

Equities

A225220

KR7225220003

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
4,035 KRW +0.12% Intraday chart for Genolution Inc. +4.26% +5.22%
Jan. 09 Tranche Update on Genolution Inc.'s Equity Buyback Plan announced on July 10, 2023. CI
Jan. 09 Tranche Update on Genolution Inc.'s Equity Buyback Plan announced on July 10, 2023. CI

Business Summary

GENOLUTION INC. is a company principally engaged in the manufacture and distribution of molecular diagnostic equipment and products related ribonucleic acid interference (RNAi) research. The Company’s products include automated nucleic acid extraction devices, nucleic acid extraction reagents and molecular diagnostic products. The Company also provides ribonucleic acid interference services. The Company distributes its products within domestic market and to overseas markets.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Nucleic Acid Extraction Reagent
68.1 %
34,083 89.5 % 6,651 68.1 % -80.48%
RNAi Co., Ltd.
13.3 %
893 2.3 % 1,301 13.3 % +45.57%
Nucleic Acid Extraction Equipment
12.8 %
3,108 8.2 % 1,252 12.8 % -59.71%
Biorad
5.3 %
- - 514 5.3 % -
Equipment Parts, Genome Analysis, etc.
0.4 %
- - 43 0.4 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
38,085 100.0 % 9,761 100.0 % -74.37%

Managers

Managers TitleAgeSince
Ki-Ok Kim CEO
 Chief Executive Officer 69 06-01-31
Yong-Ho Cho DFI
 Director of Finance/CFO 50 21-05-31
Min-Ee Kim CTO
 Chief Tech/Sci/R&D Officer 38 -
Jun-Pil Moon AUD
 Comptroller/Controller/Auditor 58 20-01-30

Members of the board

Members of the board TitleAgeSince
Hak-Soo Lee BRD
 Director/Board Member 67 20-03-19
Ki-Ok Kim CEO
 Chief Executive Officer 69 06-01-31
In-Jun Kim BRD
 Director/Board Member 71 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,190,021 13,262,879 ( 69.11 %) 1,133,996 ( 5.909 %) 69.11 %

Shareholders

NameEquities%Valuation
Hoil Biomed, Inc.
11.01 %
2,113,112 11.01 % 6 M ₩
Ki-Ok Kim
6.405 %
1,229,068 6.405 % 4 M ₩
GENOLUTION INC.
5.909 %
1,133,996 5.909 % 3 M ₩
Min-Ee Kim
2.163 %
415,000 2.163 % 1 M ₩
Min-ho Kim
2.105 %
404,000 2.105 % 1 M ₩
Sang-hoon Kim
2.105 %
404,000 2.105 % 1 M ₩
Gene X Co. Ltd.
1.433 %
275,038 1.433 % 790 638 ₩
Ek Health Services, Inc.
0.7368 %
141,400 0.7368 % 406 476 ₩
Dimensional Fund Advisors Ltd.
0.0375 %
7,195 0.0375 % 20 683 ₩
DFA Australia Ltd.
0.000349 %
67 0.000349 % 193 ₩

Holdings

NameEquities%Valuation
GENOLUTION INC.
5.91%
 1,133,996 5.91% 3,259,842 $

Company contact information

GENOLUTION, Inc.

63 Magokjungang 8-ro 3-gil Gangseo-gu

07793, Seoul

+

http://genolution.co.kr
address Genolution Inc.(A225220)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Diagnostics & Testing

Sales per Business

Sector Bio Diagnostics & Testing

1st Jan change Capi.
GENOLUTION INC. Stock Genolution Inc.
+5.22% 55.96M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-18.16% 11.03B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+58.43% 3.5B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-31.31% 2.23B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-14.31% 2.16B
VERACYTE, INC. Stock Veracyte, Inc.
-26.61% 1.54B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+34.35% 1.12B
SEEGENE, INC. Stock Seegene, Inc.
-3.28% 737M
CAREDX, INC Stock CareDx, Inc
-22.75% 477M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-40.20% 411M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. A225220 Stock
  4. Company Genolution Inc.